Silence Therapeutics (SLN) Shares Issued (2020 - 2025)
Historic Shares Issued for Silence Therapeutics (SLN) over the last 6 years, with Q2 2025 value amounting to $1000.0.
- Silence Therapeutics' Shares Issued fell 9991.61% to $1000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was -$83000.0, marking a year-over-year decrease of 10005.39%. This contributed to the annual value of $142.1 million for FY2024, which is 34489.78% up from last year.
- According to the latest figures from Q2 2025, Silence Therapeutics' Shares Issued is $1000.0, which was down 9991.61% from $14000.0 recorded in Q1 2025.
- Over the past 5 years, Silence Therapeutics' Shares Issued peaked at $133.0 million during Q1 2024, and registered a low of -$98000.0 during Q4 2024.
- Over the past 5 years, Silence Therapeutics' median Shares Issued value was $903268.4 (recorded in 2021), while the average stood at $16.7 million.
- Its Shares Issued has fluctuated over the past 5 years, first soared by 19372790.16% in 2022, then tumbled by 10085.02% in 2024.
- Quarter analysis of 5 years shows Silence Therapeutics' Shares Issued stood at $1348.0 in 2021, then skyrocketed by 10515.44% to $143097.2 in 2022, then skyrocketed by 7955.07% to $11.5 million in 2023, then tumbled by 100.85% to -$98000.0 in 2024, then skyrocketed by 101.02% to $1000.0 in 2025.
- Its last three reported values are $1000.0 in Q2 2025, $14000.0 for Q1 2025, and -$98000.0 during Q4 2024.